InsiderTrades

Form 4 for APYX Apyx Medical Corp

Accepted 2026-06-17 17:15:02 ET · period of report 2026-06-15 · accession 0001493152-26-029122 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2026-06-17 17:15 2026-06-15 APYX Roman Shawn David COO M - OptEx $3.23 +15.0K 15.0K New +$48.5K
DI 2026-06-17 17:15 2026-06-15 APYX Roman Shawn David COO F - Tax $4.60 -10.5K 16.5K -39% -$48.5K
D 2026-06-17 17:15 2026-06-15 APYX Roman Shawn David COO M - OptEx $0.00 -15.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-15 M A 15,000 $3.23 15,000 I By The Roman Family Revocable Trust — — (F1) Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.
2 Common Common Stock 2026-06-15 F D 10,533 $4.60 16,467 I By The Roman Family Revocable Trust — — (F1) Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.
3 Derivative Stock option (right to buy) 2026-06-15 M D 15,000 $0.00 0 D $3.23 · — to 2027-05-01 15,000 Common Stock (F2) On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person.